Chlamydia trachomatis Major Outer Membrane Protein (MOMP) Epitopes That Activate HLA Class II-Restricted T Cells from Infected Humans

Journal of Immunology

Volumn 157, Issue 10, 1996, Pages 4554-4567

  Ortiz, Linette ^a   Demick, Karen P ^b   Petersen, Jean W ^b   Polka, Michael ^b   Rudersdorf, Richard A ^b   Van Der Pol, Barbara ^c   Jones, Robert ^c   Angevine, Mark ^a   DeMars, Robert ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA D ANTIGEN; OUTER MEMBRANE PROTEIN;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MICROBIOLOGY; MOLECULAR GENETICS; T LYMPHOCYTE;

ALLELES; AMINO ACID SEQUENCE; BACTERIAL OUTER MEMBRANE PROTEINS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; EPITOPES; FEMALE; HLA-D ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES;

EID: 0030588607     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Piot, P., J. A. R. V.d. Hoek, L. V. Damme, and M. Laga. 1994. Epidemiology and control of genital chlamydial infection. In Chlamydial Infections. J. Orfila, G. I. Byrne, M. A. Chernesky, J. T. Grayston, R. B. Jones, G. L. Ridgway, P. Saikku, J. Schachter, W. E. Stamm, and R. S. Stephens, eds. Societa Editrice Esculapio, Bologna, Spain, p. 7.
2. Blythe, M., B. P. Katz, B. E. Batteiger, J. A. Ganser, and R. B. Jones. 1992. Recurrent genitourinary chlamydial infections in sexually active female adolescents. J. Pediatr. 121:487.
3. Byrne, G. I., R. S. Stephens, G. Ada, H. D. Caldwell, H. Su, R. P. Morrison, B. VanDer Pol, P. Bavoil, L. Bobo, S. Everson, Y. Ho, R. C. Hsia, K. Kennedy, C.-C. Kuo, P. C. Montgomery, E. Peterson, A. Swanson, C. Whitaker, J. Whittum-Hudson, C. L. Yang, Y.-X. Zhang, and G. M. Zhong. 1993. Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings. J. Infect. Dis. 168:415.
4. Zhang, Y.-X., S. Stewart, T. Joseph, H. R. Taylor and H. D. Caldwell. 1987. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J. Immunol. 138:575.
5. Su, H., R. P. Morrison, N. G. Watkins, and H. D. Caldwell. 1990. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J. Exp. Med. 172:203.
6. Allen, J. E., R. M. Locksley, and R. S. Stephens. 1991. A single peptide from the major outer membrane protein of Chlamydia trachomatis elicits T cell help for the production of antibodies to protective determinants. J. Immunol. 147:674.
7. Ishizaki, M., J. E. Allen, P. R. Beatty, and R. S. Stephens. 1992. Immune specificity of murine T-cell lines to the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 60:3714.
8. Su, H., and H. D. Caldwell. 1992. Immunogenicity of a chimeric peptide corresponding to T helper and B Cell epitopes of Chlamydia trachomatis major outer membrane protein. J. Exp. Med. 175:227.
9. Zhong, G., I. Toth, R. Reid, and R. C. Brunham. 1993. Immunogenicity evaluation of a lipidic amino acid-base peptide vaccine for Chlamydia trachomatis. J. Immunol. 151:3728.
10. Qvistad, E., K. Skaug, and E. Thorsby. 1983. Proliferative human T cell responses to Chlamydia trachomatis in vitro. Acta Pathol. Microbiol. Immunol. Scand. Sect. C Immunol. 91:203.
11. Qvistad, E., S. Digranes, and E. Thorsby. 1983. Antigen-specific proliferative human T-lymphocyte clones with specificity for Chlamydia trachomatis. Scand. J. Immunol. 18:291.
12. Qvistad, E., and E. Thorsby. 1983. Class-II HLA restriction of antigen-specific human T-lymphocyte clones. Scand. J. Immunol. 18:298.
13. Qvistad, E., T. Moen, and E. Thorsby. 1984. T-cell clones with similar antigen specificity may be restricted by DR, MT(DC), or SB class II HLA molecules. Immunogenetics 19:455.
14. Qvistad, E., K. Skaug, and H. Hirschberg. 1985. Characterization of Chlamydia trachomatis serotypes by human T-lymphocyte clones. Scand. J. Immunol. 21: 215.
15. Stagg, A. J., W. A. Elsley, M. A. Pickett, M. E. Ward, and S. C. Knight. 1993. Primary human T-cell responses to the major outer membrane protein of Chlamydia trachomatis. Immunology 79:1.
16. Van Der Pol, B. J., and R. B. Jones. 1992. Comparison of immunotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining and radioimmunoassay. J. Clin. Microbiol. 30:1014.
17. Maeda, M., N. Murayama, H. Ishii, N. Uryu, M. Ota, K. Tsuji, and H. Inako. 1989. A simple and rapid method for HLA-DQA1 genotyping by digestion of PCR-amplified DNA with allele specific restriction endonucleases. Tissue Antigens 34:290.
18. Uryu, N., M. Maeda, M. Ota, K. Tsuji, and H. Inako. 1990. A simple and rapid method for HLA-DRB and DQB typing by digestion of PCR-amplified DNA with allele specific restriction endonucleases. Tissue Antigens 35:20.
19. Maeda, M., N. Murayama, H. Ishii, M. Ota, K. Tsuji, and H. Inako. 1990. A simple and rapid method for HLA-DP genotyping by digestion of PCR-amplified DNA with allele-specific restriction endonucleases. Hum. Immunol. 27:111.
20. Hoshiro, S., A. Kimura, Y. Fukuda, K. Doki, and T. Sasazuki. 1992. Polymerase chain reaction-single strand conformation polymorphism analysis of polymorphism in DPA1 and DPB1 genes: a simple, economical, and rapid method for histocompatibilily testing. Hum. Immunol. 33:98.
21. Olerup, O., A. Aldener, and A. Fodgell. 1993. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 41:119.
22. Bodmer, J. G., S. G. E. Marsh, E. D. Albert, W. F. Bodmer, R. F. Boutrop, D. Charron, B. Dupont, H. A. Erlich, B. Mach, W. R. Mayr, P. Parham, T. Sasazuki, G. M. T. Schreuder, J. L. Strominger, A. Svejgaard, P. I. Terasaki. 1995. Nomenclature for factors of the HLA system. Tissue Antigens 46:1.
23. Ceman, S., J. W. Petersen, V. Pinet, and R. DeMars. 1994. Gene required for normal class II expression and function is localized to approximately 45 kb of DNA in the class II region of the MHC. J. Immunol. 152:2685.
24. Lasergene, 1996. (DNASTAR, Madison, WI)
25. Ceman, S., R. Rudersdorf, E. O. Long, and R. DeMars. 1992. MHC class II deletion mutant expresses normal levels of transgene encoded class II molecules that have abnormal conformation and impaired antigen presentation ability. J. Immunol. 149:754.
26. Bavoil, P., A. Ohlin, and J. Schachter. 1988. Role of disulfide bonding in outer membrane protein structure and permeability in Chlamydia trachomatis. Infect. Immun. 44:479.
27. Pharmacia Biotech. 1994. GST Fusion System. 2nd Ed. Pharmacia Biotech. Piscataway, NJ.
28. Peterson, E. M., B. A. Markoff, and L. M. de la Maza. 1990. The major outer membrane protein nucleotide sequence of Chlamydia trachomatis, serovar E. Nucleic Acid Res. 18:3414.
29. Hager, D. A., and R. R. Burgess. 1980. Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate and renaturation of enzyme activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes. Anal. Biochem. 109:76.
30. Moore, G. E., R. E. Gerner, and H. A. Franklin. 1967. Culture of normal human leukocytes. J. Am. Med. Assoc. 199:519.
31. Chen, B. P., R. DeMars, and P. Sondel. 1987. Presentation of soluble antigen to human cells by products of multiple HLA-linked loci: analysis of antigen presentation by a panel of cloned autologous HLA-mutant Epstein-Barr virus-transformed lymphoblastoid cell lines. Hum. Immunol. 18:75.
32. Tosato, G. Generation of Epstein-Barr virus (EBV)-immortalized B cell lines. 1991. In Current Protocols in Immunology, Vol. 2. J. E. Coligan, A. M. Kruisbeek, D. A. Margulies, E. M. Shevach, W. Strober, eds. Wiley Interscience, New York, p. 7.22.2.
33. DeMars, R., C C. Chang, and R. Rudersdorf. 1983. Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line. Hum. Immunol. 8:123.
34. Kavathas, P., F. H. Bach, and R. DeMars. 1980. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 77:4251.
35. Nadon, N., G. Sekhon, L. Brown, N. Korn, J. W. Petersen, J. Strandtmann, C. Chang, and R. DeMars. 1986. Derepression of the HPRT locus on the inactive X chromosome of a human lymphoblastoid cell line. Somat. Cell Mol. Genet. 12:541.
36. Evans, A. M., J. W. Petersen, G. S. Sekhon, and R. DeMars. 1989. Mapping of prolactin and tumor necrosis factor-beta genes on human chromosome 6p using lymphoblastoid cell deletion mutants. Somat. Cell Mol. Genet. 15:203.
37. DeMars, R., C. C. Chang, S. Shaw, P. J. Reitnauer, and P. M. Sondel. 1984. Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutants that have decreased expression of HLA Class II antigens. Hum. Immunol. 11:77.
38. Erlich, H., J. S. Lee, J. W. Petersen, T. Bugawan, and R. DeMars. 1986. Molecular analysis of HLA class I and class II antigen loss mutant reveals a homozygous deletion of the DR, DQ and part of the DP region: implications for class II gene order. Hum. Immunol. 16:205.
39. Ceman, S., R. Rudersdorf, J. W. Petersen, and R. DeMars. 1995. DMA and DMB are the only genes in the class II region of the Human MHC needed for class II-associated antigen processing. J. Immunol. 154:2545.
40. Lampson, L. A., and R. Levy. 1980. Two populations of la-like molecules on a human B cell line. J. Immunol. 125:293.
41. Parham, P., T. J. Kipps, F. E. Ward, and L. A. Herzenberg. 1983. Isolation of heavy chain class switch variants of a monoclonal anti-DC1 hybridoma cell line: effective conversion of non-cytotoxic IgG1 antibodies to cytotoxic IgG2 antibodies. Hum. Immunol. 8:141.
42. Giles, R. C., G. Nunez, C. K. Hurley, A. Nunez-Roldan, R. Winchester, P. Stastny, and J. D. Capra. 1983. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J. Exp. Med. 157:1461.
43. Watson, A. J., R. DeMars, I. S. Trowbridge, and F. H. Bach. 1983. Detection of a novel human class II HLA antigen. Nature 304:358.
44. Harlow, E., and D. Lahe. 1988. Antibody purification on protein A columns. In Antibodies, A Laboratory Manual. Cold Spring Harbor Press, Cold Spring Harbor, NY, p. 310.
45. Rotzschke, O., and K. Falk. 1994. Origin, structure and motifs of naturally processed MHC class II ligands. Curr. Opin. Immunol 6:45.
46. Trowsdale, J., J. Ragoussis, and R. D. Campbell. 1991. Map of the human MHC. Immunol. Today 12:445.
47. Reitnaver, P. J., R. DeMars, and P. M. Sondel. 1986. The proliferative response to autologous Epstein-Barr virus-transformed cells. II. Studies with HLA class II loss variants demonstrate a role for gene products other than DR and DQ. Hum. Immunol. 16:276.
48. Knight, S. C., S. Iqball, C. Woods, A. Stagg, M. E. Ward, and M. Tuffrey. 1995. A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo. Immunology 85:8.
49. Su, H., M. Parnell, and H. D. Caldwell. 1995. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection. Vaccine 13:1023.